Clinical Trial Update: Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a single-arm Phase 1/2 study evaluating an infliximab biosimilar for moderate to severe chronic plaque psoriasis, focusing on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Infliximab biosimilar

Snippet

Sponsor: Services Institute of Medical Sciences, Pakistan | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING